Bronchoscopy Market

Global Bronchoscopy Market is valued at USD 2.46 Billion in 2022 and expected to reach USD 4.06 Billion by 2029 with a CAGR of 7.41% over the forecast period.

Global Bronchoscopy Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, and 2023-2029- Increasing incidences of respiratory diseases, growing geriatric population, and rising advancement in technology are some of the major factors driving the growth of the Global Bronchoscopy Market.

Scope-

Bronchoscopy is a medical procedure that allows a doctor to examine the inside of a person's airways, including the trachea (windpipe) and the bronchi (the tubes that branch off from the trachea into the lungs). During the procedure, a bronchoscope (a flexible or rigid tube with a light and camera on the end) is inserted through the mouth or nose and down the throat, into the airways. There are different types of bronchoscopies that can be performed depending on the reason for the procedure. A diagnostic bronchoscopy is done to investigate the cause of respiratory symptoms, such as persistent cough, chest pain, or difficulty breathing. During a diagnostic bronchoscopy, the doctor may take samples of tissue or fluid from the airways for further testing. A therapeutic bronchoscopy may be done to remove foreign objects, clear mucus, or other obstructions from the airways, or to treat certain lung conditions, such as lung cancer or pulmonary fibrosis. The first recorded bronchoscopy was performed by the ancient Greek physician Hippocrates in the 5th century BCE. He used a reed to examine the throats of his patients and diagnose respiratory conditions.

The Covid-19 pandemic has had a significant impact on the global bronchoscopy market. The reduction in elective procedures due to the pandemic has resulted in a decline in the number of bronchoscopy procedures being performed, leading to a decrease in revenue for companies operating in the market. However, the market is expected to rebound as the pandemic comes under control, and the backlog of postponed procedures is addressed. In addition, the need for bronchoscopy procedures to diagnose and treat respiratory diseases, including Covid-19, is expected to drive demand in the market in the long term.

The global bronchoscopy market is segmented based on product, use, and region & country level. Based on product, the global bronchoscopy market is segmented into endoscopy, visualization and documentation system, accessories and others. Based on use, the market is segmented into disposable/single use, and reusable.

The regions covered in the global bronchoscopy market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global bronchoscopy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players-

Some major key players for the global bronchoscopy market report cover prominent players like -

• Ambu A/S
• Karl Storz
• Cook Medical
• Fujifilm Holdings Corporation
• Boston Scientific
• Olympus Corporation
• Hoya Corporation
• Richard Wolf GmbH
• Lymol Medical
• Hoffmann-La Roche Ltd
• others

Segmentation-

By Product Type:

• Endoscopy
• Visualization and documentation system
• Accessories
• Others

By Use:

• Disposable/Single use
• Reusable

By Regional & Country Level:

• North America

  • U.S.
  • Canada

• Europe

  • U.K.
  • France
  • Germany
  • Italy

• Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia

• Latin America

  • Brazil
  • Mexico

• Middle East and Africa

  • GCC
  • Africa
  • Rest of Middle East and Africa

Market Dynamics-

One of the major factors driving the growth of the global bronchoscopy market is the increasing incidences of respiratory diseases. The rising incidences of respiratory diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and pneumonia is a major driver of the bronchoscopy market. Bronchoscopy is an essential tool in the diagnosis and treatment of these diseases. For instance; as per the Forum of International Respiratory Societies report 2022, around 200 million people are projected to have COPD, and 262 million people are impacted by Asthma.

In addition, the growing geriatric population is also boosting the bronchoscopy market growth. The growing elderly population is at a higher risk of developing respiratory diseases, leading to an increase in the demand for bronchoscopy procedures further drives the market growth. For example; according to World Health Organization (WHO), the populace aged 60 years and over will increment from one billion of every 2020 to 1.4 billion. By 2050, the total populace of people aged 60 years and older will double that is 2.1 billion. The quantity of people aged 80 years or more established is supposed to significantly increase somewhere in the range of 2020 and 2050 to arrive at 426 million.

Moreover, the rising number of advancements in technology are also supplementing the market growth. Advances in bronchoscopy technology, including the development of digital bronchoscopes and virtual bronchoscopes, have improved the accuracy and safety of the procedure. These advancements have increased the demand for bronchoscopy procedures. For example; in August 2021, Boston Logical Organization got U.S. FDA 510(k) clearance for the EXALT Model B Single-Use Bronchoscope, intended for use in bedside procedures inside the intensive care unit it and operating room.

However, lack of skilled physicians and pulmonologist and strict regulatory processes may hamper the growth of the global bronchoscopy market. Despite that, developing and marketing innovative bronchoscopy devices and accessories, such as robotic-assisted bronchoscopy systems and advanced imaging technologies may provide an opportunity for the further growth of the market. 

Regional Analysis-

North America is expected to dominate the global bronchoscopy market within the forecast period due to the rising prevalence rates of respiratory diseases such as lung cancer, COPD, and pneumonia, the technological advancement, and presence of key players in this region. For example; as per the American Cancer Society’s estimates, in 2023, about 238,340 new cases of lung cancer and around 127,070 deaths from lung cancer in the Unites States. Also, technological advancements also drive the bronchoscopy market in the region over the forecast period. For example; in July 2021, Verathon launched the GlideScope BFlex single-use bronchoscope which gives the accessibility of a single-use bronchoscope while delivering the pictures and control normally connected with a reusable bronchoscope.

Asia Pacific is the fastest-growing region in the global bronchoscopy market because of a rising cases of chronic obstructive pneumonic disease and supportive government initiatives in this region. For instance; as per the Journal of Association of Pulmonologist of Tamil Nadu, Chronic obstructive pneumonic disease (COPD) is the second driving reason for death in India, which influences approximately 53 million individuals.

News-

Ambu Announced FDA Clearance of Fifth-Generation Single-Use Bronchoscope

On July 27^th, 2022; Ambu Inc. announced that Ambu aScopeTM 5 Broncho, a group of single-use, sterile bronchoscopes, has gotten 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA). With the aScope 5 Broncho, Ambu currently drives the section of single-use endoscopes in the bronchoscopy suite, a market fragment known for its extensively complex operations, procedures that require extents of high-performance picture quality and handling. To enter this market, the aScope 5 Broncho family has advanced imaging and design highlights, including another high-goal camera chip, which, in blend with the aBox 2, delivers superior picture quality.

Olympus Awarded Bronchoscopy Solutions Agreement with Premier, Inc.

On May 31^st, 2022; Olympus announced it has been granted a group purchasing agreement in the Single- Use Visualization Devices classification for its single-use bronchoscope portfolio with Chief, Inc. The Olympus single-use bronchoscope portfolio is comprised of the five premium H-SteriScope single-use bronchoscopes that can be utilized in supplement with Olympus' driving re-usable bronchoscope portfolio, currently accessible under the Chief Adaptable Careful Endoscopy arrangement. Thusly, Olympus is at present the main supplier of a full-range bronchoscopy solution, which is planned to give doctors the right endoscope, for the right persistent, in the right situation.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2022:	USD 2.46 Billion
Base year considered	2021
Forecast Period CAGR %:	10.8%
Market Size Expected in 2029:	USD 7.41 Billion
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Ambu A/S, Karl Storz, Cook Medical, Fujifilm Holdings Corporation, Boston Scientific, Olympus Corporation, Hoya Corporation, Richard Wolf GmbH, Lymol Medical, F. Hoffmann-La Roche Ltd, and others
Segments Covered	By Product Type, By Use
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa